ibandronic acid has been researched along with Fibrocartilaginous Dysplasia of Bone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Economidou, D; Ginikopoulou, E; Memmos, D; Minasidis, E; Mitsopoulos, E; Pateinakis, P; Thodis, E; Tsakiris, D; Vargemezis, V; Zanos, S | 1 |
1 other study(ies) available for ibandronic acid and Fibrocartilaginous Dysplasia of Bone
| Article | Year |
|---|---|
Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study.
Topics: Aged; Biopsy; Bone Density; Bone Density Conservation Agents; Cinacalcet; Diphosphonates; Female; Femur Neck; Fibrous Dysplasia of Bone; Humans; Ibandronic Acid; Lumbar Vertebrae; Male; Middle Aged; Naphthalenes; Pilot Projects; Renal Dialysis; Risk; Teriparatide; Treatment Outcome | 2012 |